EcoDrugPlus

Prostaglandin E Receptor 3

Ensembl ID : ENSOSIG00000021489
Gene Symbol: PTGER3
1 Cross references
194 Possible Orthologues:

Prostaglandin E Receptor 4 (Subtype Ep4) A

Ensembl ID : ENSOSIG00000021949
Gene Symbol: PTGER4A
1 Cross references
202 Possible Orthologues:

Prostaglandin E Receptor 4 (Subtype Ep4) B

Ensembl ID : ENSOSIG00000009855
Gene Symbol: PTGER4B
1 Cross references
201 Possible Orthologues:

Prostaglandin F Receptor (Fp)

Ensembl ID : ENSOSIG00000023948
Gene Symbol: PTGFR
1 Cross references
195 Possible Orthologues:

Prostaglandin I2 Receptor

Ensembl ID : ENSOSIG00000007743
Gene Symbol: PTGIR
1 Cross references
187 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSOSIG00000010877
Gene Symbol: PTGS1
1 Cross references
182 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSOSIG00000000959
Gene Symbol: PTGS1
1 Cross references
212 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2b

Ensembl ID : ENSOSIG00000017867
Gene Symbol: PTGS2B
1 Cross references
214 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSOSIG00000018278
Gene Symbol: PSMA1
1 Cross references
270 Possible Orthologues:

Proteasome 20s Subunit Alpha 2a

Ensembl ID : ENSOSIG00000017322
Gene Symbol: PSMA2A
1 Cross references
269 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSOSIG00000018012
Gene Symbol: PSMA3
1 Cross references
238 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSOSIG00000000130
Gene Symbol: PSMA4
1 Cross references
214 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).